# Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells

> **NCT02881970** · PHASE1,PHASE2 · RECRUITING · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 20 (estimated)

## Conditions studied

- Neonatal Hypoxic-ischaemic Encephalopathy

## Interventions

- **DRUG:** autologous cord blood stem cell

## Key facts

- **NCT ID:** NCT02881970
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-05
- **Primary completion:** 2028-04
- **Final completion:** 2028-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02881970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02881970, "Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02881970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*